GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Margin of Safety % (DCF FCF Based)

EyeGene (XKRX:185490) Margin of Safety % (DCF FCF Based) : N/A (As of May. 01, 2025)


View and export this data going back to 2015. Start your Free Trial

What is EyeGene Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

EyeGene's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


Competitive Comparison of EyeGene's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, EyeGene's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EyeGene's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EyeGene's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where EyeGene's Margin of Safety % (DCF FCF Based) falls into.


;
;

EyeGene Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of EyeGene's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


EyeGene Business Description

Industry
Traded in Other Exchanges
N/A
Address
Gangseo-gu, Seoul 401, B-dong 910 Gayang-dong, Seoul, KOR, 07528
EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.

EyeGene Headlines

No Headlines